| Item type: | Article | ||||
|---|---|---|---|---|---|
| Journal or Publication Title: | PLOS ONE | ||||
| Publisher: | PUBLIC LIBRARY SCIENCE | ||||
| Place of Publication: | SAN FRANCISCO | ||||
| Volume: | 18 | ||||
| Number of Issue or Book Chapter: | 11 | ||||
| Page Range: | e0293869 | ||||
| Date: | 2023 | ||||
| Institutions: | Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||
| Identification Number: |
| ||||
| Keywords: | PREVALENCE; DISEASE; COSTS; | ||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 76351 |
Web of ScienceAbstract
BackgroundCongenital cytomegalovirus (cCMV) infection can have a broad range of manifestations. This study aimed to assess cCMV-associated sequelae and healthcare resource utilization (HCRU) in infants during the first year of life in Germany.MethodsA retrospective, controlled cohort study using German claims data from the Institute for Applied Health Research Berlin (InGef) database was ...
Abstract
BackgroundCongenital cytomegalovirus (cCMV) infection can have a broad range of manifestations. This study aimed to assess cCMV-associated sequelae and healthcare resource utilization (HCRU) in infants during the first year of life in Germany.MethodsA retrospective, controlled cohort study using German claims data from the Institute for Applied Health Research Berlin (InGef) database was conducted. cCMV-associated sequelae and HCRU during the first year of life were assessed by matching (1:60) infants with at least one inpatient/outpatient cCMV diagnosis (ICD-10-GM: P35.1) <= 90 days after birth (cCMV(90) cohort) and infants with at least one inpatient cCMV diagnosis plus specific sequelae <= 21 days after birth (cCMV(21-S)) to infants without cCMV or CMV (ICD-10-GM: B25) diagnosis (control group), respectively. Outcomes were analyzed during the first 365 days of life.ResultsBetween 2014-2018, we identified 54 newborns for cCMV(90) and 24 newborns for cCMV(21-S) cohort. Compared to the 3,240 and 1,440 controls, respectively, more cCMV(90) infants (83.3% vs. 41.9%, p<0.01) presented with at least one sequela during the first year of life, including intrauterine growth retardation (42.6% vs. 5.3%, p<0.01), sensorineural hearing loss (SNHL) to deafness (38.9% vs. 2.2%, p<0.01), and motor development disorders (33.3% vs. 10.9%, p<0.01). Further, 13.0% of cCMV(90) infants (vs. 2.3%, p<0.01) suffered from visual impairment. In cCMV(21-S) cohort, intrauterine growth retardation (79.2% vs. 6.0%, p<0.01), prematurity (54.2% vs. 7.3%, p<0.01), and motor development disorders (50.0% vs. 11.0%, p<0.01) were the most frequent sequelae. Infants in the cCMV(90) and cCMV(21-S) cohort had, on average, 7.3 times and 9.5 times more hospitalizations and 2.0 times and 2.1 times more outpatient physician visits than their respective controls (p<0.01). Hospitalized infants with cCMV stayed, on average, significantly longer in hospital compared to their controls (cCMV(90) cohort: 30.3 days vs. 9.0 days, p<0.01; cCMV(21-S) cohort: 46.5 days vs. 9.3 days, p<0.01).ConclusionscCMV-infection shows a considerable disease and healthcare burden during the first year of life. More than 80% of the identified newborns with cCMV suffered from at least one associated sequela during the first year of life, including long-term sequelae such as SNHL (40%) and visual impairment (13%). Additional steps for prevention of cCMV infection and associated sequelae as well as a comprehensive monitoring of disease burden are needed.
Metadata last modified: 18 Mar 2025 10:12
Article Level Metrics (PLOS)